Clinical Trial

The Acute Effects of Onnit Alpha Brain on Cognition and Mood States

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this randomized, double-blind, placebo-controlled crossover study is to evaluate the efficacy of the acute effects of an investigational supplement (Alpha Brain or Alpha Brain 2.0) on improving cognitive performance, vigilance, and subjective mood in healthy adults compared to placebo during a period of acute sleep deprivation under conditions of controlled sleep deprivation.
Protocol Amendment History 4 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-07-09
notable Primary completion moved earlier: 2026-08-01 -> 2026-06-26 2026-07-09
minor Completion moved earlier: 2026-08-15 -> 2026-06-26 2026-07-09
critical Primary endpoint(s) modified 2026-04-04
Trial Details
NCT Number NCT07495592
Lead Sponsor Applied Science & Performance Institute
Conditions Cognitive, Mood and Cognitive Performance, Sleep Deprivation, Executive Function (Cognition), Fatigue
Enrollment 32 participants
Start Date 2026-05-01
Primary Completion 2026-06-26 (estimated)
Study Completion 2026-06-26 (estimated)
Updated on ClinicalTrials.gov 2026-07-08